Fairview Capital Investment Management, LLC Abb Vie Inc. Transaction History
Fairview Capital Investment Management, LLC
- $1.67 Billion
- Q1 2024
A detailed history of Fairview Capital Investment Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Fairview Capital Investment Management, LLC holds 12,988 shares of ABBV stock, worth $2.16 Million. This represents 0.14% of its overall portfolio holdings.
Number of Shares
12,988
Previous 12,830
1.23%
Holding current value
$2.16 Million
Previous $1.99 Million
18.96%
% of portfolio
0.14%
Previous 0.12%
Shares
13 transactions
Others Institutions Holding ABBV
# of Institutions
3,654Shares Held
1.24BCall Options Held
15.5MPut Options Held
11.6M-
Vanguard Group Inc Valley Forge, PA170MShares$28.4 Billion0.62% of portfolio
-
Black Rock Inc. New York, NY143MShares$23.8 Billion0.61% of portfolio
-
State Street Corp Boston, MA78MShares$13 Billion0.64% of portfolio
-
Jpmorgan Chase & CO New York, NY51.3MShares$8.54 Billion0.85% of portfolio
-
Capital International Investors Los Angeles, CA48.1MShares$8.01 Billion1.81% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $294B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...